Pulmonx Corp
(NAS:LUNG)
$
7.11
-0.01 (-0.14%)
Market Cap: 280.76 Mil
Enterprise Value: 229.18 Mil
PE Ratio: 0
PB Ratio: 2.99
GF Score: 59/100 Pulmonx Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 13, 2021 / 08:15PM GMT
Release Date Price:
$38.24
(-1.52%)
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst
Good afternoon, and thank you for joining us for the third day of the 2021 Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst and a member of the health care research team here at Morgan Stanley. It's my pleasure to have Pulmonx with us today, Glen French, President and CEO; and Derrick Sung, CFO.
And before we begin, I'll run through our disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
And with that, Glen, Derrick, thank you both for joining us today.
Glendon E. French
Pulmonx Corporation - CEO, President & Director
Thank you.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot